SCHEMBL23730843

SCHEMBL23730843

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)c5sc6ccccc6c5c4)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
ALOX5 P09917 1/20 0.43
MAPT P10636 3/20 0.42
PIM3 Q86V86 2/20 0.42
LIMK1 P53667 2/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
ATM Q13315 2/20 0.39
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
GPR3 P46089 1/20 0.36
PIM1 P11309 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
NTSR1 P30989 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25645934 1.00 TNKS (0.43) TNKSTNKS2ALOX5MAPTPIM3
SCHEMBL25645939 1.00 TNKS (0.43) TNKSTNKS2ALOX5MAPTPIM3
SCHEMBL21108866 1.00 TNKS (0.43) TNKSTNKS2ALOX5MAPTPIM3
SCHEMBL23623304 1.00 TNKS (0.43) TNKSTNKS2ALOX5MAPTPIM3
SCHEMBL17425679 0.99 TNKS (0.43) TNKSTNKS2ALOX5MAPTPIM3
SCHEMBL26047803 0.95 ALOX5 (0.42) TNKSTNKS2ALOX5MAPTPIM3
SCHEMBL25645935 0.95 ALOX5 (0.42) TNKSTNKS2ALOX5MAPTPIM3
SCHEMBL23331709 0.94 PIK3CA (0.39) TNKSTNKS2ALOX5MAPTPIM3
SCHEMBL23331711 0.92 TNKS (0.39) TNKSTNKS2ALOX5MAPTPIM3
SCHEMBL25645914 0.91 TNKS (0.43) TNKSTNKS2ALOX5MAPTPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11081655-B2 Heterocyclic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11081655-B2 Heterocyclic compound and organic light emitting device using the same CRY1, CYP1B1, CYBA TNKS 2480/4885TNKS2 3289/4885ALOX5 328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.